Skip to main content

Trey Carlton Mullikin

Assistant Professor of Radiation Oncology
Radiation Oncology

Current Appointments & Affiliations


Assistant Professor of Radiation Oncology · 2024 - Present Radiation Oncology, Clinical Science Departments
Member of the Duke Cancer Institute · 2022 - Present Duke Cancer Institute, Institutes and Centers

In the News


Published July 10, 2025
How Duke is Transforming Care for Brain and Spine Metastasis

View All News

Recent Publications


Broadening clinical trial inclusivity of patients with lung cancer and brain metastases utilizing the Graded Prognostic Assessment (GPA): A call to action.

Journal Article Lung Cancer · February 10, 2026 Brain metastases (BM) occur in 30-50% of non-small cell lung cancer (NSCLC) and up to 80% of small cell lung cancer (SCLC) patients, yet historically over 80% of clinical trials excluded this population. Current eligibility requirements often mandate compl ... Full text Link to item Cite

Poly ADP Ribose Polymerase Inhibitors Potentiate Proton Therapy End-of-Range Effects by Accelerating Replication Forks and Promoting Transcription Conflict.

Journal Article Int J Radiat Oncol Biol Phys · February 1, 2026 PURPOSE: Poly ADP ribose polymerase inhibitors (PARPi) are being combined with photon and proton radiation therapy in clinical trials. We sought to investigate mechanisms of PARPi radiosensitization at varying linear energy transfer (LET) levels after obse ... Full text Link to item Cite

Comparison of Local Medicare Guidance and Medicare Advantage Plans for Stereotactic Radiosurgery for Brain Metastases.

Journal Article Adv Radiat Oncol · February 2026 PURPOSE: Medicare Advantage operates under a capitated payment model, where Medicare Advantage Organizations (MAOs) must provide services that meet or exceed Medicare Parts A and B standards, ensuring actuarial equivalence. MAOs are mandated to base their ... Full text Link to item Cite
View All Publications

Education


Mayo Clinic, Alix School of Medicine · 2016 M.D.